Esma inan Inan Yuksel

Dr. Esma inan Inan Yuksel

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in Cureus
Verified
Journal Article
Open access
PDF file
DCDemet Cicek
Demet Cicek
BDBetul Demir
Betul Demir
KSKazim Sahin
Kazim Sahin
MTMehmet Tuzcu
Mehmet Tuzcu
COCemal Orhan
Cemal Orhan
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel
Background Exosomes are membrane-derived nanovesicles produced by cells and play an important role in intercellular communication. Objectives This study aimed to investigate the effects of garlic exosome (GE) on hair growth. Methods Forty-two Sprague-Dawley/Wistar albino rats were randomly divided into six groups: non-shaved control, shaved control, topical control, GE 2 mg, GE 4 mg, and topical GE. At the end of the experiment, the number of hair follicles, follicle diameter, and subcutaneous tissue thicknesses were measured histopathologically. The Wnt-1, β-catenin, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and collagen I levels were measured by the Western Blot method. Results The anagen follicle counts of the GE 2 mg, 4 mg, and topical GE groups were 66.57±15.49, 105.71±25.06, and 55.29±6.72, and were significantly higher than the control groups (p<0.01, p<0.001 and p<0.05, respectively). The follicle diameter of the GE 4 mg group was higher than the others (p<0.05). The Wnt-1, PDGF, VEGF, TGF-β1, and collagen I levels of all GE groups, and the β-catenin levels of the GE 4 mg and topical GE groups were significantly higher than the control groups (p<0.05). Conclusion GE induces hair growth in rats via the Wnt-1, β-catenin, VEGF, PDGF, and TGF-β1 signaling pathways.

5 June 2021 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
SUS. Arslan Uku
S. Arslan Uku
BDB. Demir
B. Demir
DCD. Cicek
D. Cicek
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel

13 May 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
BDBetul Demir
Betul Demir
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel
DCDemet Cicek
Demet Cicek
STSedatcan Turkoglu
Sedatcan Turkoglu

20 May 2022 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel
BDBetul Demir
Betul Demir
DCDemet Cicek
Demet Cicek
KSKazim Sahin
Kazim Sahin
MTMehmet Tuzcu
Mehmet Tuzcu
FSFikrettin Sahin
Fikrettin Sahin

24 May 2021 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel
APAsude Kara Polat
Asude Kara Polat
MKMuge Gore Karaali
Muge Gore Karaali
AAAyse Esra Koku Aksu
Ayse Esra Koku Aksu
MGMehmet Salih Gurel
Mehmet Salih Gurel
Herpes zoster (HZ) is an infectious disease caused by latent varicella-zoster virus reactivation. There are conflicting reports on the varicella vaccine's effect on the incidence of HZ in children and adolescents. This study aimed to determine the impact of the single dose of varicella vaccination on HZ prevalence during childhood and adolescence. The study included children and adolescents aged <18 years who presented to the dermatology outpatient clinic between 2005 and 2019 and were diagnosed with HZ. Considering that the universal vaccination program started to be implemented in Turkey in 2013, non-vaccinated cases in the prevaccination period, vaccinated cases in the postvaccination period, and non-vaccinated patients in the postvaccination period were compared in terms of HZ prevalence and demographic features. After the initiation of the varicella vaccination program, the prevalence of HZ was found to decrease by 24.7% in all. The HZ prevalence was significantly reduced in vaccinated children, while the rate of decrease in non-vaccinated children was low (58.6% and 16.4%, respectively). The median age of the non-vaccinated cases in the postvaccination period (10 [min 0.5-max 17] years) was significantly higher compared to the other groups (p < 0.001). The number of cases aged <2 years was the highest in the vaccinated group (p < 0.001). Administration of a single dose of varicella vaccine was insufficient to decrease the prevalence of HZ <18 years of age. In the post-vaccination period, the frequency of HZ in unvaccinated cases increased in adolescence. In vaccinated children, HZ seems to develop at an earlier age.

6 December 2013 in Journal of Chemotherapy
Verified
Journal Article
Closed access
TYTansu Yamazhan
Tansu Yamazhan
BKBehice Kurtaran
Behice Kurtaran
HPHüsnü Pullukçu
Hüsnü Pullukçu
EYEsma inan Inan Yuksel
Esma inan Inan Yuksel
DÖDeniz Özkaya
Deniz Özkaya
HAHasan Salih Zeki Aksu
Hasan Salih Zeki Aksu
In this study, we aimed to evaluate the 1-year post-treatment follow-up results of 112 patients who received pegylated interferon (PEG-IFN) for 52 weeks. HBeAg negativity/seroconversion and/or negative HBV-DNA at the end of the treatment were considered as response. Patients who had response at the end of treatment but had HBV-DNA breakthrough during 1-year follow-up were considered as relapse. The study group comprised 112 cases (34 HBeAg-positive, 78 HBeAg-negative). In HBeAg-positive and -negative cases, end-of-treatment response rates were 2·9% and 60·2%, whereas 1-year sustained virological response rates were 0 and 33·3%, respectively. When we compared relapse cases versus cases with response at the end of 1-year follow-up, being female and having low viral load were the two parameters associated with higher response rates (Chi-square, P = 0·028; Mann-Whitney U test, P = 0·023). Overall non-response rates to PEG-IFN were high (57·1%). Results in HBeAg-positive cases were disappointing.